Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gallion
Holly Gallion, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100143948 | CHEMO-SENSITIVITY ASSAYS USING TUMOR CELLS EXHIBITING PERSISTENT PHENOTYPIC CHARACTERISTICS - The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cellular and secreted markers, for screening cells to detect phenotypic and genotypic drift and for predicting chemotherapeutic response of patient tumor cells to at least one therapeutic agent. The assays, methods, tools and systems discussed herein also represent an improved and unified system for monitoring and for screening multiple pharmaceutical agents for efficacy and long term effect as to a specific patient. | 06-10-2010 |
Kirk P. Gallion, Pottstown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100063860 | Method for managing a business process related to a document publishing project - Management of the processes involved with document publishing involves identifying tasks associated with the processing of information that is to form the publication and assigning worker resources to such tasks. Time to complete the tasks are estimated and schedules are developed. Actual work time is measured. Reports are generated and a planning tool is provided. | 03-11-2010 |
Steven L. Gallion, Willingford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100160292 | Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors - Methods of inhibiting BTK activity by inhibiting phosphorylation of Y551 of BTK, methods of treating patients by inhibiting BTK activity by inhibiting phosphorylation of Y551 of BTK, chemical entities that bind to BTK and inhibited complexes are provided. | 06-24-2010 |
